TD Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.2M | Buy |
|
|||||
|
2025
Q1 | $77.9M | Buy |
|
|||||
|
2024
Q4 | $73.1M | Buy |
|
|||||
|
2024
Q3 | $78.6M | Buy |
|
|||||
|
2024
Q2 | $72.3M | Buy |
|
|||||
|
2024
Q1 | $68.8M | Buy |
|
|||||
|
2023
Q4 | $69.5M | Sell |
|
|||||
|
2023
Q3 | $97.7M | Sell |
|
|||||
|
2023
Q2 | $125M | Sell |
|
|||||
|
2023
Q1 | $152M | Sell |
|
|||||
|
2022
Q4 | $460M | Sell |
|
|||||
|
2022
Q3 | $411M | Sell |
|
|||||
|
2022
Q2 | $492M | Buy |
|
|||||
|
2022
Q1 | $465M | Buy |
|
|||||
|
2021
Q4 | $461M | Buy |
|
|||||
|
2021
Q3 | $155M | Buy |
|
|||||
|
2021
Q2 | $144M | Buy |
|
|||||
|
2021
Q1 | $115M | Buy |
|
|||||
|
2020
Q4 | $117M | Sell |
|
|||||
|
2020
Q3 | $113M | Sell |
|
|||||
|
2020
Q2 | $166M | Sell |
|
|||||
|
2020
Q1 | $344M | Buy |
|
|||||
|
2019
Q4 | $369M | Sell |
|
|||||
|
2019
Q3 | $342M | Buy |
|
|||||
|
2019
Q2 | $404M | Buy |
|
|||||
|
2019
Q1 | $393M | Buy |
|
|||||
|
2018
Q4 | $381M | Buy |
|
|||||
|
2018
Q3 | $379M | Sell |
|
|||||
|
2018
Q2 | $322M | Buy |
|
|||||
|
2018
Q1 | $309M | Buy |
|
|||||
|
2017
Q4 | $290M | Buy |
|
|||||
|
2017
Q3 | $271M | Buy |
|
|||||
|
2017
Q2 | $170M | Sell |
|
|||||
|
2017
Q1 | $175M | Buy |
|
|||||
|
2016
Q4 | $155M | Sell |
|
|||||
|
2016
Q3 | $197M | Buy |
|
|||||
|
2016
Q2 | $204M | Sell |
|
|||||
|
2016
Q1 | $200M | Buy |
|
|||||
|
2015
Q4 | $206M | Buy |
|
|||||
|
2015
Q3 | $200M | Buy |
|
|||||
|
2015
Q2 | $211M | Buy |
|
|||||
|
2015
Q1 | $200M | Sell |
|
|||||
|
2014
Q4 | $183M | Buy |
|
|||||
|
2014
Q3 | $142M | Buy |
|
|||||
|
2014
Q2 | $138M | Sell |
|
|||||
|
2014
Q1 | $153M | Sell |
|
|||||
|
2013
Q4 | $213M | Sell |
|
|||||
|
2013
Q3 | $203M | Sell |
|
|||||
|
2013
Q2 | $207M | Buy |
|